Nielsen Biosciences, Inc.

This study tested a treatment called Candin for common warts in 330 people aged 12 and older. Participants received injections into one wart every two weeks until it cleared, then were monitored for 12 more weeks. The goal was to see if Candin works better than a placebo at makin…